These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29027122)

  • 1. Hi1a as a Novel Neuroprotective Agent for Ischemic Stroke by Inhibition of Acid-Sensing Ion Channel 1a.
    Ren Y; Li C; Chang J; Wang R; Wang Y; Chu XP
    Transl Stroke Res; 2018 Apr; 9(2):96-98. PubMed ID: 29027122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a.
    Chassagnon IR; McCarthy CA; Chin YK; Pineda SS; Keramidas A; Mobli M; Pham V; De Silva TM; Lynch JW; Widdop RE; Rash LD; King GF
    Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3750-3755. PubMed ID: 28320941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total Synthesis of the Spider-Venom Peptide Hi1a.
    Duggan NM; Saez NJ; Clayton D; Budusan E; Watson EE; Tucker IJ; Rash LD; King GF; Payne RJ
    Org Lett; 2021 Nov; 23(21):8375-8379. PubMed ID: 34632783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PcTx1 affords neuroprotection in a conscious model of stroke in hypertensive rats via selective inhibition of ASIC1a.
    McCarthy CA; Rash LD; Chassagnon IR; King GF; Widdop RE
    Neuropharmacology; 2015 Dec; 99():650-7. PubMed ID: 26320544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective potential of Piroxicam in cerebral ischemia: an in silico evaluation of the hypothesis to explore its therapeutic efficacy by inhibition of aquaporin-4 and acid sensing ion channel1a.
    Bhattacharya P; Pandey AK; Paul S; Patnaik R
    Med Hypotheses; 2012 Sep; 79(3):352-7. PubMed ID: 22795752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and molecular interaction studies of a highly stable, tarantula peptide modulator of acid-sensing ion channel 1.
    Er SY; Cristofori-Armstrong B; Escoubas P; Rash LD
    Neuropharmacology; 2017 Dec; 127():185-195. PubMed ID: 28327374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disrupted Ionic Homeostasis in Ischemic Stroke and New Therapeutic Targets.
    Hu HJ; Song M
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2706-2719. PubMed ID: 29054733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Peptide Ligation Strategies for the Synthesis of the Bivalent Acid-Sensing Ion Channel Inhibitor Hi1a.
    Tran HNT; Budusan E; Saez NJ; Norman A; Tucker IJ; King GF; Payne RJ; Rash LD; Vetter I; Schroeder CI
    Org Lett; 2023 Jun; 25(24):4439-4444. PubMed ID: 37306339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-sensitive cation channels and ion exchangers in ischemic brain injury: new therapeutic targets for stroke?
    Leng T; Shi Y; Xiong ZG; Sun D
    Prog Neurobiol; 2014 Apr; 115():189-209. PubMed ID: 24467911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolysis and neuroprotection in cerebral ischemia.
    Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
    Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational strategies for neuroprotection in ischemic stroke--focusing on acid-sensing ion channel 1a.
    O'Bryant Z; Vann KT; Xiong ZG
    Transl Stroke Res; 2014 Feb; 5(1):59-68. PubMed ID: 24390970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental neuroprotection in ischemic stroke: a concise review.
    Rajah GB; Ding Y
    Neurosurg Focus; 2017 Apr; 42(4):E2. PubMed ID: 28366067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of neuroprotective agents in the treatment of acute ischemic stroke.
    Lutsep HL; Clark WM
    Curr Neurol Neurosci Rep; 2001 Jan; 1(1):13-8. PubMed ID: 11898495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection via AT
    Bennion DM; Steckelings UM; Sumners C
    Clin Sci (Lond); 2018 May; 132(10):1055-1067. PubMed ID: 29802210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental therapy approaches for ischemic stroke].
    Kleinschnitz C; Plesnila N
    Nervenarzt; 2012 Oct; 83(10):1275-81. PubMed ID: 23015194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated brain restoration after ischemic stroke--medical management, risk factors, nutrients, and other interventions for managing inflammation and enhancing brain plasticity.
    Kidd PM
    Altern Med Rev; 2009 Mar; 14(1):14-35. PubMed ID: 19364191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection for ischemic stroke: past, present and future.
    Ginsberg MD
    Neuropharmacology; 2008 Sep; 55(3):363-89. PubMed ID: 18308347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Window of opportunity: estrogen as a treatment for ischemic stroke.
    Liu R; Yang SH
    Brain Res; 2013 Jun; 1514():83-90. PubMed ID: 23340160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin-dependent kinase inhibition with roscovitine: neuroprotection in acute ischemic stroke.
    Timsit S; Menn B
    Clin Pharmacol Ther; 2012 Feb; 91(2):327-32. PubMed ID: 22218073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: from review to preview.
    Grupke S; Hall J; Dobbs M; Bix GJ; Fraser JF
    Clin Neurol Neurosurg; 2015 Feb; 129():1-9. PubMed ID: 25497127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.